Background: A common practice used prior to induction of labor (IOL) is
cervical ripening. Currently, there is no consensus from world scientific
societies on the method of first choice. One of the most popular method is
prostaglandin PGE2 (dinoprostone) usage. It is used in different doses and
pharmaceutical forms. Methods: In our analysis we compared the
obstetrical outcome of IOL using a dinoprostone vaginal insert (DVI) with 10 mg
of dinoprostone, which released 0.3 mg/h of dinoprostone for 24 hours
(Cervidil
Induction of labor (IOL) is one of the most common procedures performed in obstetrics. Currently, in developed countries, up to one in four deliveries is induced [1]. Due to the results of the ARRIVE trial [2] indicating the benefits of labor induction in healthy pregnant nulliparous woman after 39 weeks of gestation, the prevalence of IOLs may increase in the coming years. Cervical ripening is a naturally occurring process prior to the spontaneous onset of delivery. In case of unfavorable cervix we have to employ cervical ripening agents to minimize the risk of cesarean section (CS) and shorten the patient’s length of stay in the delivery room. Choosing the best method for cervical ripening is difficult. This is due to the wide variety of agents available as well as the many criteria for evaluating these methods used in clinical trials. In the evaluation of individual methods, the environment in which the study group is embedded must also be taken into account. Local conditions such as the prevalence of CS and obstetricians’ attitudes towards this method of pregnancy completion vary considerably between countries. For this reason, observational studies play an important role in the evaluation of pre-induction methods by presenting real world data.
The Bishop score (BS) [3] has remained the gold standard for cervical assessment for almost 60 years. This scoring scale is used worldwide to assess the chance of successful IOL in a given patient. It has been shown that the individual axes of the scale as well as the total score have a negative predictive ability in relation to the delivery completion through CS [4]. At the same time, the need for pre-induction itself seems to reduce the odds of vaginal delivery [5].
In our study, we compared the obstetric outcomes of using two methods of
pre-inducing labor in patients with unfavorable cervix (BS
Our study was single-center, retrospective and observational. We reviewed medical records of patients who delivered at the Department of Obstetrics and Gynecology, Provincial Combined Hospital in Kielce (tertiary referral ward). Approval for the study was granted by the bioethics committee at Jan Kochanowski University in Kielce. Informed consent was obtained from all subjects involved in the study.
In the study we included first 100 patients (since product was introduced in our
Clinic practice) who underwent IOL with DVI (01.01.2018–1.10.2020) and have
unfavorable cervix (BS
Patients with singleton, term pregnancy, cephalic presentation of fetus, intact
fetal membranes and unfavorable cervix (BS
The DVI and Foley catheter were maintained for a maximum of 24 hours. DVI and
Foley catheter were removed in case of initiation of active phase of labor
(dilation
Statistical analysis was performed using Statistica 13.1 software (Tibco
Software Inc., Palo Alto, CA, USA). For qualitative variables, we presented data
as percentage of events per group and odds ratio (OR) (DVI vs Foley group) with
95% confidence interval (CI). We compared the qualitative variables using
Pearson’s
A total of 456 patients (100 - DVI, 356 Foley catheter) were included in the analysis. In both groups, the most common indication for IOL was postdate pregnancy (63% in DVI and 68% in Foley group respectively, P = 0.34), gestational diabetes (14% and 16%, P = 0.61) and hypertensive disorders in pregnancy (13% and 9%, P = 0.45) the other indications were, accordingly 10% and 7% (P = 0.55).
All patients were Caucasian. Baseline characteristics of the patients are shown
in Table 1. The groups did not differ in the percentage of multiparous women or
median gestational age at IOL time. Epidural anesthesia was more common in the
group of patients induced with the Foley catheter. Obstetrical outcomes are
presented in Table 2. In the group of patients pre-induced with DVI, labor
augmentation with oxytocin was used less frequently (OR = 0.35, 95% CI
0.23–0.57), MSAF was observed less often (OR = 0.38, 95% CI = 0.15–0.99), but
the difference was on the borderline of statistical significance. Other observed
outcomes including percentage of CS and VE, incidence of postpartum haemorrhage,
failed induction (18 hours of oxytocin infusion without achieving active stage of
labor), unreassuring CTG trace were not significantly different between groups.
Neonatal birth status as measured clinically by the Apgar scale also did not
differ between groups. The groups did not differ in the percentage of newborns
born with pH
Foley (n = 356) | DVI (n = 100) | P | |
age (years, SD) | 28.39 (4.72) | 29.02 (3.6) | P = 0.84 |
pluripara | 21.63% | 25.00% | P = 0.47478 |
gestational age (weeks, IQR) | 40 (0.8) | 40 (0.7) | P = 0.92 |
epidural analgesia | 21.07% | 10.00% | P = 0.01204 |
SD, standard deviation; IQR, interquartile range. |
Foley group (n = 356) | DVI group (n = 100) | P | OR (95% CI) | |
cesarean section | 27.53% | 22.00% | P = 0.26733 | 0.74 (0.44–1.26) |
vacuum extraction | 1.69% | 4.00% | P =0.16259 | 2.43 (0.67–8.79) |
oxitocin augumentation | 62.08% | 37.00% | P = 0.00001 | 0.35 (0.23–0.57) |
meconium stained amniotic fluid | 12.08% | 5.00% | P = 0.04155 | 0.38 (0.15–0.99) |
placental abruption | 0.28% | 0.00% | P = 0.59571 | N/A |
postpartum hemorrhage | 2.25% | 3.00% | P = 0.66463 | 1.35 (0.35–5.17) |
failed induction or arrested labor (as CS indication) | 13.48% | 11.00% | P = 0.51330 | 0.79 (0.4–1.59) |
unreassuring CTG trace (as operative delivery indication) | 11.24% | 7.00% | P = 0.21833 | 0.59 (0.26–1.37) |
1st minute Apgar |
3.66% | 7.00% | P = 0.15035 | 1.98 (0.77–5.1) |
5th minute Apgar |
1.69% | 2.00% | P = 0.83503 | 1.18 (0.24–5.97) |
pH |
2.25% | 4.00% | P = 0.33328 | 1.81 (0.53–6.14) |
pH |
0.00% | 1.00% | P = 0.05891 | N/A |
pH (median, IQR) | 7.351 (0.086) | 7.3745 (0.0675) | P = 0.001 | N/A |
Intracervical Foley catheter is one of the most common methods used for cervical ripening. Its popularity is due primarily to its low cost, but also to its low rate of complications, efficacy and the limited number of patients in whom it is contraindicated. However, taking into account the induction to delivery time (IDT) its effectiveness compared to most biochemical methods is lower [9, 10]. The chance of vaginal delivery within 24 hours after induction is lower than with prostaglandins PGE1 (misoprostol) and PGE2 (dinoprostone) regardless of the route or method of prostaglandin administration. The absolute probability of VD not achieving in 24 hours for the Foley catheter is estimated at 0.65 (95% Credible interval (Crl) 0.48–0.79) [9] with dinoprostone the probability of VD not achieving in 24 hours ranges from 0.52 to 0.62 depending on the form of administration (vaginal insert, gel or vaginal tablet) [9]. The chance of completing labor via CS is not different with the Foley catheter and prostaglandin PGE2 [9].
The above mentioned indicators (absolute probability of VD not achieving in 24 hours and ITD) are particularly important in the context of cost-effectiveness analysis of the studied product. Longer IOL time translates directly into involvement of maternal ward staff. Reducing IOL time especially in the nulliparous female group on a population scale may translate into a reduction in the number of medical staff positions needed. Thus, current research directions focus on the one hand on selecting pre-induction for its potency of action and on the other hand on its applicability in outpatient’s settings, while maintaining the highest possible level of safety for both mother and child. Randomized trials available in the literature comparing the form of dinoprostone analyzed in our study—DVI with Foley catheter in terms of IDT are not conclusive, but a meta-analysis of six randomized trials published in 2016 shows a shorter IDT in patients induced with DVI (mean difference [MD] = 5.73 h, P = 0.01 in favor of DVI) while showing no advantage in the percentage of patients who delivered vaginally within 24 h (38.4% in the Foley group and 45.3% in DVI group, P = 0.31) and no difference in CS rates. Oxytocin was used more frequently during IOL in the Foley group (RR = 1.86 95% CI 1.25–2.77) [10]. In most centers, oxytocin administration requires adequate and continuous fetal monitoring and takes place in the delivery room. Less frequent oxytocin administration may translate into shorter stay of patients in the delivery room and possibility of greater mobility due to lack of connection of the patient to the infusion pump.
Only a low rate of adverse effects will allow the transfer of labor
pre-induction from hospital to outpatient settings. Studies show that among two
most commonly used prostaglandins, i.e., dinoprostone and misoprostol,
prostaglandin PGE2 is the safer substance in terms of adverse maternal and
neonatal outcome. Use of misoprostol in comparison to dinoprostone is associated
with higher risk of postpartum haemorrhage (aOR = 4.62 95% CI 3.27–6.54),
postpartum maternal blood transfusion (aOR = 1.31 95% CI 1.01–1.71), neonatal
intensive care unit admission of newborn born after 37 weeks of gestation (aOR =
1.37 95% CI 1.07–1.75), Apgar
In our study, we did not show differences in the birth status of newborns. The
advantage of our analysis is the assessment of cord blood pH in all newborns
(percentage of missing data—0.3%). The acid-base analysis of cord blood is a
test with greater predictive ability in relation to the neurological development
of the child in the future compared to the clinical assessment on the Apgar scale
[7, 8]. In our opinion, the fact that the median pH values differ between the
groups is of little clinical significance. Despite the difference in medians
between the groups, both values are within the range of normal pH. One should
also keep in mind the sensitivity of the median to extreme values and outliers.
From a clinical point of view, the percentage of newborns with pH
An important aspect to consider when evaluating a pre-induction method is
patient satisfaction with the method used. In our opinion, patient satisfaction
is an underreported outcome in the literature. We found no studies in directly
comparing the satisfaction of patients pre-induced with DVI and Foley catheter.
Given the discomfort experienced by the patient during mechanical cervical
dilation, and the more complicated insertion process compared to inserts or
vaginal tablets, the intracervical Foley may be a less satisfying and more
concerning method compared to biochemical methods. We found one 2003 study
compared intracervical misoprostol (50
A limitation of our study was the lack of adjustment of OR for potential confounding factors (such as BMI or epidural analgesia [EA]). However, the groups by including all patients eligible for IOL over a given time period using the selected method reflect the general population and do not differ in demographic characteristics (except for the proportion of patients who received EA). However, the 2018 Cohrane meta-analysis did not indicate that intrapartum use of EA was associated with an increased risk of CS and worse neonatal birth outcomes [20].
Obstetric outcomes and neonatal clinical status do not differ regardless of whether DVI or the Foley catheter was used to pre-induce labor in patients in term pregnancy with intact fetal membranes.
In the group of patients pre-induced with the use of the Foley catheter the necessity to augment labor with oxytocin is more frequent.
These should be presented as follows: JM, MM designed the research study. JM, MM performed the research. JA collected dataset. JM analyzed the data. JM, MM wrote the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.
Informed consent was obtained from all subjects involved in the study. Protocol of study was approved by the Ethics Committee of Jan Kochanowski University in Kielce (approval number: 03/21).
Project financed under the program of the Minister of Science and Higher Education called “Regional Initiative of Excellence” in the years 2019–2022, project no. 024/RID/2018/19, amount of financing 11 999 000,00 zł.
This research received no external funding.
Authors declare no conflict of interests.
The data that support the findings of this study are available in OSF Storage at DOI: 10.17605/OSF.IO/JS2V4.